APA (7th ed.) Citation

Arnold, S. M., Rinehart, J. J., Tsakalozou, E., Eckardt, J. R., Fields, S. Z., Shelton, B. J., . . . Leggas, M. (2010). A Phase I Study of 7-t-Butyldimethylsilyl-10-Hydroxycamptothecin in Adult Patients with Refractory or Metastatic Solid Malignancies. Clinical cancer research, 16(2), 673-680. https://doi.org/10.1158/1078-0432.CCR-09-2429

Chicago Style (17th ed.) Citation

Arnold, Susanne M., et al. "A Phase I Study of 7-t-Butyldimethylsilyl-10-Hydroxycamptothecin in Adult Patients with Refractory or Metastatic Solid Malignancies." Clinical Cancer Research 16, no. 2 (2010): 673-680. https://doi.org/10.1158/1078-0432.CCR-09-2429.

MLA (9th ed.) Citation

Arnold, Susanne M., et al. "A Phase I Study of 7-t-Butyldimethylsilyl-10-Hydroxycamptothecin in Adult Patients with Refractory or Metastatic Solid Malignancies." Clinical Cancer Research, vol. 16, no. 2, 2010, pp. 673-680, https://doi.org/10.1158/1078-0432.CCR-09-2429.